0001104659-15-012649.txt : 20150220
0001104659-15-012649.hdr.sgml : 20150220
20150220164738
ACCESSION NUMBER: 0001104659-15-012649
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150212
FILED AS OF DATE: 20150220
DATE AS OF CHANGE: 20150220
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NPS PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000890465
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 870439579
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 550 HILLS DRIVE
CITY: BEDMINSTER
STATE: NJ
ZIP: 07921
BUSINESS PHONE: (908) 450-5300
MAIL ADDRESS:
STREET 1: 550 HILLS DRIVE
CITY: BEDMINSTER
STATE: NJ
ZIP: 07921
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Selisker Rachel R
CENTRAL INDEX KEY: 0001313793
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-23272
FILM NUMBER: 15636316
MAIL ADDRESS:
STREET 1: 550 HILLS DRIVE
STREET 2: 3RD FLOOR
CITY: BEDMINSTER
STATE: NJ
ZIP: 07921
4
1
a4.xml
4
X0306
4
2015-02-12
0
0000890465
NPS PHARMACEUTICALS INC
NPSP
0001313793
Selisker Rachel R
550 HILLS DRIVE
BEDMINSTER
NJ
07921
1
0
0
0
Restricted Stock Units
2015-02-12
4
A
0
3816
0
A
Common Stock
3816
3816
D
Each Restricted Stock Unit was awarded under NPS Pharmaceuticals Inc.'s (the "Issuer") amended and restated 2005 Omnibus Incentive Plan and represents a contingent right to receive one share of the Issuer's common stock.
One hundred percent of the Restricted Stock Units will vest on the first anniversary of the date of grant. Vested shares will be delivered to the reporting person as soon as administratively practicable following the vesting of the Restricted Stock Units.
/s/ Rachel R. Selisker, by Jill Thompson as attorney-in-fact
2015-02-19